Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma
Clinical trial NCT01711528 · COMPLETED
Trial details
- NCT number
- NCT01711528
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-19
- Primary completion
- 2016-11-22
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.